Iovance Biotherapeutics, Inc. stock jumps 130% in 2026 but RSI screams overbought
Covered by 1 source · 1 article
Iovance Biotherapeutics, Inc. stock has become a standout momentum story in 2026, closing at $6.98 on volume of roughly 17.4 million shares. With the stock up more than 130% this year, the focus shifts from trend direction to how far the ra…
Covered by
